Apogee Therapeutics Inc.

NASDAQ: APGE · Real-Time Price · USD
37.36
-0.76 (-1.99%)
At close: Aug 15, 2025, 3:59 PM
36.48
-2.36%
After-hours: Aug 15, 2025, 07:58 PM EDT

Apogee Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
Net Income
-182.15M -83.98M -39.78M
Depreciation & Amortization
189K n/a n/a
Stock-Based Compensation
23.33M 6.1M 2.14M
Other Working Capital
-930K 4.49M 9.4M
Other Non-Cash Items
-10.55M -2.98M 11.4M
Deferred Income Tax
n/a n/a n/a
Change in Working Capital
-2M 6.11M 9.81M
Operating Cash Flow
-171.17M -74.76M -16.43M
Capital Expenditures
-1.15M -167K n/a
Cash Acquisitions
n/a n/a n/a
Purchase of Investments
-649.45M -303.74M n/a
Sales Maturities Of Investments
350.14M 30M n/a
Other Investing Acitivies
n/a n/a n/a
Investing Cash Flow
-300.46M -273.91M n/a
Debt Repayment
n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
1.63M n/a 183.62K
Financial Cash Flow
495.11M 315.39M 183.62K
Net Cash Flow
23.47M -33.28M -16.24M
Free Cash Flow
-172.33M -74.93M -16.43M